Serum soluble CD27, but not thymidine kinase, is an independent Prognostic factor for outcome in indolent non-Hodgkin's lymphomaKOK, Marleen; BONFRER, Johannes M; KORSE, Catharina M et al.Tumor biology. 2003, Vol 24, Num 1, pp 53-60, issn 1010-4283, 8 p.Article

Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancerIKEGUCHI, Masahide; YAMAGUCHI, Ken-Ichi; KAIBARA, Nobuaki et al.Tumor biology. 2003, Vol 24, Num 1, pp 40-45, issn 1010-4283, 6 p.Article

Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell linesWIDNEY, Daniel; BOSCARDIN, W. John; KASRAVI, Arjang et al.Tumor biology. 2003, Vol 24, Num 2, pp 82-93, issn 1010-4283, 12 p.Article

Expression of adipocyte-derived leucine aminopeptidase in endometrial cancer: Association with tumor grade and CA-125KAZETO, Hideo; NOMURA, Seiji; KIKKAWA, Fumitaka et al.Tumor biology. 2003, Vol 24, Num 4, pp 203-208, issn 1010-4283, 6 p.Article

Serum insulin-like growth factor-II and α-fetoprotein as tumor markers of hepatocellular carcinomaTSAI, J. F; JENG, J. E; LIN, Z. Y et al.Tumor biology. 2003, Vol 24, Num 6, pp 291-298, issn 1010-4283, 8 p.Article

The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): Analysis in Italian patientsRUZZO, Annamaria; GRAZIANO, Francesco; MAGNANI, Mauro et al.Tumor biology. 2003, Vol 24, Num 3, pp 147-150, issn 1010-4283, 4 p.Article

Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factorsMOLINA, R; FILELLA, X; BARREIRO, E et al.Tumor biology. 2003, Vol 24, Num 4, pp 209-218, issn 1010-4283, 10 p.Article

Frequent alterations of the β-catenin protein in cancer of the uterine cervixPEREIRA-SUAREZ, Ana Laura; MERAZ, Marco Antonio; GARCIA-CARRANCA, Alejandro et al.Tumor biology. 2002, Vol 23, Num 1, pp 45-53, issn 1010-4283Article

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma: Possible role of vascular endothelial growth factorYOSHIJI, Hitoshi; KURIYAMA, Shigeki; FUKUI, Hiroshi et al.Tumor biology. 2002, Vol 23, Num 6, pp 348-356, issn 1010-4283, 9 p.Article

Detection of mammaglobin in the sera of patients with breast cancerFANGER, Gary R; HOUGHTON, Raymond L; FLEMING, Timothy P et al.Tumor biology. 2002, Vol 23, Num 4, pp 212-221, issn 1010-4283, 10 p.Article

Low levels of endostatin in the urine from patients with malignant diseaseLINDER-STRAGLIOTTO, Christina; STRANDER, Hans; MUNCK-WIKLAND, Eva et al.Tumor biology. 2002, Vol 23, Num 4, pp 222-227, issn 1010-4283, 6 p.Article

Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigenDORVILLIUS, Mylène; GARAMBOIS, Véronique; POURQUIER, Didier et al.Tumor biology. 2002, Vol 23, Num 6, pp 337-347, issn 1010-4283, 11 p.Article

Translational Cancer Research: Abstracts, The XXXth Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2002, September 8-12, 2002, Boston, MassTumor biology. 2002, Vol 23, issn 1010-4283, 77 p., SUP1Conference Proceedings

Behavior of murine renal carcinoma cells grown in ectopic or orthotopic sites in syngeneic miceAHN, Kwang-Sung; JUNG, Yoo-Sun; JHINGOOK KIM et al.Tumor biology. 2001, Vol 22, Num 3, pp 146-153, issn 1010-4283Article

Comparison of Cyfra 21-1 and SCC assays in head and neck tumoursBANAL, A; HACENE, K; BERTHELOT-RUFF, E et al.Tumor biology. 2001, Vol 22, Num 1, pp 27-35, issn 1010-4283Article

Comparison of two prognostic markers for malignant melanoma : MIA and S100 βJUERGENSEN, Andrea; HOLZAPFEL, Ute; HEIN, Rüdiger et al.Tumor biology. 2001, Vol 22, Num 1, pp 54-58, issn 1010-4283Article

Effects of dextranation on the uptake of peptides in micrometastases : Studies on Binding of EGF in tumor spheroidsNILSSON, Per; GEDDA, Lars; SJÖSTRÖM, Anna et al.Tumor biology. 2001, Vol 22, Num 4, pp 229-238, issn 1010-4283Article

Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinomaTAKANAMI, Iwao; TAKEUCHI, Ken; KARUKE, Masao et al.Tumor biology. 2001, Vol 22, Num 4, pp 205-210, issn 1010-4283Article

Lactacystin inhibits cathepsin A activity in melanoma cell linesKOZŁOWSKI, Leszek; STOKŁOSA, Tomasz; OMURA, Satoshi et al.Tumor biology. 2001, Vol 22, Num 4, pp 211-215, issn 1010-4283Article

Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomasWOLF, H. K; STÖBER, C; HOHENFELLNER, R et al.Tumor biology. 2001, Vol 22, Num 5, pp 328-336, issn 1010-4283Article

Prognostic value of serum sialyl Lewis^a, sialyl Lewis^x and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patientsNAKAGOE, Tohru; SAWAI, Terumitsu; TSUJI, Takashi et al.Tumor biology. 2001, Vol 22, Num 2, pp 115-122, issn 1010-4283Article

Rare somatic p53 mutation identified in breast cancer : A case reportSMARDOVA, J; NEMAJEROVA, A; TRBUSEK, M et al.Tumor biology. 2001, Vol 22, Num 2, pp 59-66, issn 1010-4283Article

Roles of growth factors in mediating mesenchymal influence on the cytodifferentiation of the Dunning prostatic adenocarcinomaLU, X. F; TAM, N. C; WONG, Y. C et al.Tumor biology. 2000, Vol 21, Num 1, pp 21-32, issn 1010-4283Article

Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCRMURAKAMI, A; SUMINAMIA, Y; SAKAGUCHI, Y et al.Tumor biology. 2000, Vol 21, Num 4, pp 224-234, issn 1010-4283Article

Vanadate is toxic to adherent-growing multidrug-resistant cellsCAPELLA, L. S; ALCANTARA, J. S. M; MOURA-NETO, V et al.Tumor biology. 2000, Vol 21, Num 1, pp 54-62, issn 1010-4283Article